X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
67
PharmaCompass offers a list of Trametinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trametinib manufacturer or Trametinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trametinib manufacturer or Trametinib supplier.
PharmaCompass also assists you with knowing the Trametinib API Price utilized in the formulation of products. Trametinib API Price is not always fixed or binding as the Trametinib Price is obtained through a variety of data sources. The Trametinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trametinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trametinib, including repackagers and relabelers. The FDA regulates Trametinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trametinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trametinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trametinib supplier is an individual or a company that provides Trametinib active pharmaceutical ingredient (API) or Trametinib finished formulations upon request. The Trametinib suppliers may include Trametinib API manufacturers, exporters, distributors and traders.
click here to find a list of Trametinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trametinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Trametinib active pharmaceutical ingredient (API) in detail. Different forms of Trametinib DMFs exist exist since differing nations have different regulations, such as Trametinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trametinib DMF submitted to regulatory agencies in the US is known as a USDMF. Trametinib USDMF includes data on Trametinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trametinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trametinib suppliers with USDMF on PharmaCompass.
A Trametinib written confirmation (Trametinib WC) is an official document issued by a regulatory agency to a Trametinib manufacturer, verifying that the manufacturing facility of a Trametinib active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trametinib APIs or Trametinib finished pharmaceutical products to another nation, regulatory agencies frequently require a Trametinib WC (written confirmation) as part of the regulatory process.
click here to find a list of Trametinib suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trametinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trametinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trametinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trametinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trametinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trametinib suppliers with NDC on PharmaCompass.
Trametinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trametinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trametinib GMP manufacturer or Trametinib GMP API supplier for your needs.
A Trametinib CoA (Certificate of Analysis) is a formal document that attests to Trametinib's compliance with Trametinib specifications and serves as a tool for batch-level quality control.
Trametinib CoA mostly includes findings from lab analyses of a specific batch. For each Trametinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trametinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Trametinib EP), Trametinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trametinib USP).
Market Place
